BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,088,702 | +74.1% | 23,896 | +55.0% | 0.10% | +43.5% |
| Q1 2023 | $625,435 | +83.7% | 15,420 | +130.9% | 0.07% | +81.6% |
| Q4 2022 | $340,378 | -79.4% | 6,678 | -74.0% | 0.04% | -70.8% |
| Q2 2022 | $1,649,000 | +40.8% | 25,670 | +69.9% | 0.13% | +39.8% |
| Q1 2022 | $1,171,000 | +137.5% | 15,106 | +146.6% | 0.09% | +210.0% |
| Q3 2021 | $493,000 | -91.3% | 6,126 | -91.3% | 0.03% | -91.0% |
| Q2 2021 | $5,673,000 | -21.8% | 70,469 | -18.1% | 0.34% | -17.3% |
| Q1 2021 | $7,256,000 | -10.6% | 86,037 | -15.0% | 0.40% | -0.7% |
| Q4 2020 | $8,119,000 | +145.0% | 101,188 | +162.9% | 0.41% | +134.5% |
| Q2 2020 | $3,314,000 | +107.6% | 38,485 | +95.8% | 0.17% | +17.6% |
| Q1 2020 | $1,596,000 | -78.5% | 19,657 | -77.8% | 0.15% | -61.6% |
| Q4 2019 | $7,417,000 | +3349.8% | 88,694 | +2040.3% | 0.38% | +305.3% |
| Q1 2017 | $215,000 | – | 4,144 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
| THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
| SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
| Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
| 13D Management LLC | 194,807 | $11,794,000 | 4.18% |
| Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
| Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
| Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
| PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |